Reduced Ovarian Function
Treatment may affect ovarian reserve and overall reproductive response.
Cancer Patients can access Surrogacy through modern fertility medicine, donor programs when needed, and compassionate surrogates
Cancer treatments such as chemotherapy, radiation therapy, and certain surgical procedures may affect fertility or the ability to safely carry a pregnancy.
Treatment may affect ovarian reserve and overall reproductive response.
Some therapies or procedures can directly impact reproductive health.
Changes in hormone balance may alter fertility or reproductive timing.
In some situations, physicians may advise against carrying a pregnancy.
While these effects can make natural pregnancy difficult or impossible, modern reproductive medicine provides alternative pathways to parenthood.
Surrogacy may be recommended when pregnancy could pose health risks or is medically impossible.
Through gestational surrogacy, embryos created through IVF are transferred to a surrogate who carries the pregnancy.
Because the surrogate does not contribute genetic material, the intended parent remains the biological parent when their own eggs or sperm are used.
This pathway allows cancer survivors to pursue parenthood while protecting their health.
Many cancer patients now preserve their fertility before starting treatment through egg or embryo freezing.
If embryos were frozen before treatment, they can later be used to create a pregnancy through surrogacy.
Previously frozen embryos are carefully prepared for the next stage of treatment.
The surrogate’s cycle is coordinated so the embryo transfer can be medically timed and supported.
Once implantation occurs, the pregnancy is followed with careful medical monitoring.
This approach allows patients to move forward with parenthood after recovery.
If fertility preservation was not possible prior to treatment, donor programs may provide an alternative pathway.
Depending on the situation, intended parents may move forward with one of several donor-supported options.
Intended parents may work with an egg donor to create embryos through IVF.
In some situations, a sperm donor may provide the pathway needed for embryo creation.
Some intended parents may pursue parenthood through both donor egg and donor sperm programs.
This allows intended parents to pursue parenthood even when fertility has been affected by treatment.
Embryos are created through in vitro fertilization (IVF), using a carefully coordinated medical process designed to support intended parents on their path to surrogacy.
Eggs may be retrieved from the intended parent or from a donor, depending on the pathway being used.
Eggs are fertilized in the laboratory as part of the IVF process under specialist supervision.
Embryos are monitored as they develop, helping physicians determine the next medical steps.
When appropriate, optional genetic screening may be used as part of embryo planning.
Once embryos are created, they are transferred to the surrogate who will carry the pregnancy.
After a successful embryo transfer, the pregnancy journey begins.
Even when intended parents live far away, modern technology allows them to stay connected.
These updates help families remain closely connected to the pregnancy journey.
Visual updates help intended parents follow the pregnancy as it progresses.
Heartbeat recordings create a meaningful sense of presence and connection from afar.
Important progress markers help intended parents remain involved throughout the journey.
Advanced imaging can make the experience feel even more immediate and personal.
At Sovereign Surrogacy, we provide intended parents with compassionate and knowledgeable guidance at every stage since we recognize the special emotional and medical factors involved in these journeys.
If you are a cancer survivor exploring surrogacy, our team is here to help you understand the options available and guide you through the process.